United Therapeutics Corporation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
United Therapeutics Corporation (UTHR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$2.04 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2016-02-25
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2015 was -$2.04M.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2014 was -$461.00K, a 539.05% decline from fiscal 2013.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2013 was $105.00K.
- United Therapeutics Corporation effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2012 was -$2.68M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2015-12-31 | -$2.04M 10-K · filed 2016-02-25 |
| 2014-12-31 | -$461.00K 10-K · filed 2016-02-25 |
| 2013-12-31 | $105.00K 10-K · filed 2016-02-25 |
| 2012-12-31 | -$2.68M 10-K · filed 2015-02-24 |
| 2011-12-31 | -$1.93M 10-K · filed 2014-02-25 |
| 2010-12-31 | $451.00K 10-K · filed 2013-02-26 |
| 2009-12-31 | $1.29M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |